Fenugreek Leaf (Trigonella foenum-graecum)

Fenugreek leaf (Trigonella foenum-graecum) contains saponins and flavonoids that may help regulate blood glucose levels. The leaf extracts demonstrate antifungal activity and potential metabolic benefits, though most research focuses on fenugreek seeds.

Origin & History

Fenugreek leaf derives from Trigonella foenum-graecum L., an annual herb native to the Mediterranean region, southern Europe, and western Asia. The leaves are harvested fresh or dried and processed via aqueous or ethanolic extraction methods, such as cold maceration for 7 days, to yield extracts used in formulations like gels or capsules.

Historical & Cultural Context

Fenugreek has been used for over 2000 years in traditional systems like Ayurveda and Unani medicine for diabetes, digestion, lactation, and inflammation. Leaves specifically have been employed in Middle Eastern and Indian cuisines and traditional remedies for skin conditions.

Health Benefits

• Blood sugar management: Limited evidence from seed extract studies (1000mg/day Fenfuro® significantly reduced HbA1c, fasting and post-prandial glucose in type 2 diabetes patients, n=42, PMID: 38863744)
• Antifungal properties: In vitro studies showed leaf extracts active against Malassezia furfur (dandruff-related yeast), though no human trials exist
• Potential liver protection: Preclinical data suggest hepatoprotective effects in hepatocellular carcinoma models via apoptosis induction and ROS generation, but no human studies yet
• Nutritional density: Classified as USDA nutrient-dense food due to high fiber, vitamin, and mineral content
• Traditional digestive support: Historical use in Ayurvedic medicine for digestion, though specific leaf studies lacking

How It Works

Fenugreek leaves contain saponins, particularly diosgenin, and flavonoids that may enhance insulin sensitivity and glucose uptake in peripheral tissues. The antifungal properties appear to be mediated through bioactive compounds that disrupt fungal cell membrane integrity. These compounds may also influence carbohydrate metabolism through modulation of key glycolytic enzymes.

Scientific Research

Clinical evidence for fenugreek leaf specifically is limited, with most research focusing on seed extracts. A randomized, double-blind, placebo-controlled trial (n=104 enrolled, 42 completers) tested Fenfuro® seed extract at 1000 mg/day for 12 weeks in type 2 diabetes patients, showing significant glucose reductions (PMID: 38863744). A multicenter review of 23 trials found consistent safety across fenugreek preparations, though leaf-specific human RCTs are absent.

Clinical Summary

Most clinical evidence comes from fenugreek seed studies rather than leaf preparations. One study using Fenfuro® seed extract (1000mg daily) showed significant reductions in HbA1c, fasting glucose, and post-meal glucose in 42 type 2 diabetes patients. In vitro studies demonstrate that fenugreek leaf extracts exhibit antifungal activity against Malassezia furfur. Human studies specifically examining fenugreek leaf preparations are limited, making clinical efficacy difficult to establish.

Nutritional Profile

Fresh fenugreek leaves (per 100g edible portion): Macronutrients — Protein: 4.4g (notably high for a leafy vegetable, containing essential amino acids including lysine and tryptophan); Carbohydrates: 6.0g; Dietary fiber: 2.7g (mix of soluble galactomannans and insoluble cellulose); Fat: 0.9g; Water: ~86g; Energy: ~49 kcal. Key Micronutrients — Iron: 16.5mg (exceptionally high, though non-heme form with bioavailability estimated 2–8%; enhanced by co-consumption with vitamin C present in same leaf); Calcium: 395mg (bioavailability reduced by oxalate content ~1.3g/100g, estimated absorption ~5–10%); Vitamin C: 52mg (supports iron absorption, heat-labile — reduces ~50% on cooking); Vitamin K1: ~100–140mcg (clinically relevant for anticoagulant drug interactions); Folate: 57mcg DFE; Potassium: 770mg; Magnesium: 67mg; Phosphorus: 51mg; Zinc: 1.7mg; Manganese: 1.2mg; Beta-carotene (pro-vitamin A): ~2.85mg (converts to ~475mcg RAE, though conversion efficiency variable at ~12:1 ratio for vegetables). Bioactive Compounds — Trigonelline: present in leaves (~0.13–0.36% dry weight), a pyridine alkaloid with demonstrated hypoglycemic and neuroprotective properties in preclinical models; 4-Hydroxyisoleucine: amino acid derivative (~0.1% dry weight), proposed insulin secretagogue mechanism; Saponins (diosgenin glycosides): ~0.6–1.8% dry weight, contribute to bitter taste and proposed cholesterol-lowering effects; Flavonoids: primarily vitexin, isovitexin, and quercetin derivatives (~28–45mg/100g fresh weight), with antioxidant ORAC values estimated 900–1200 µmol TE/100g; Chlorophyll a and b: ~320mg/100g combined (fresh); Phytic acid: ~0.8g/100g (reduces mineral bioavailability — iron, zinc, calcium). Bioavailability Notes — Blanching or light steaming reduces oxalates and phytates by ~20–30%, modestly improving mineral absorption; trigonelline is partially converted to nicotinic acid (niacin) upon roasting/heating; fat-soluble beta-carotene absorption improved with concurrent dietary fat. Dried fenugreek leaf (kasuri methi, per 100g): Protein ~28g, Iron ~33mg, Calcium ~1070mg, Vitamin C largely destroyed — concentrations approximately 6–7x fresh weight values for heat-stable nutrients.

Preparation & Dosage

No standardized human dosages established specifically for fenugreek leaf. Seed extract studies used 1000 mg/day (500 mg × 2 capsules) of standardized Fenfuro® for 12 weeks. Leaf preparations in research included aqueous/ethanolic extracts via 7-day cold maceration, formulated into gels for topical use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cinnamon extract, Gymnema sylvestre, Chromium picolinate, Alpha-lipoic acid, Bitter melon

Safety & Interactions

Fenugreek leaves are generally recognized as safe when consumed as food, but supplement safety data is limited. The herb may enhance the effects of diabetes medications, potentially causing hypoglycemia when combined with insulin or oral hypoglycemic agents. Fenugreek can affect blood clotting and may interact with anticoagulant medications. Pregnant women should avoid medicinal doses as fenugreek may stimulate uterine contractions.